Catalyst Wire Dossier Catalyst Wire Dossier

Fruquintinib capsules

fruquintinib · Jiangsu Hengrui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fruquintinib capsules, covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer [Phase 2]

See pricing